Skip to main content

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Publication ,  Journal Article
Goetz, MP; Gradishar, WJ; Anderson, BO; Abraham, J; Aft, R; Allison, KH; Blair, SL; Burstein, HJ; Dang, C; Elias, AD; Farrar, WB; Giordano, SH ...
Published in: J Natl Compr Canc Netw
February 2019

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2019

Volume

17

Issue

2

Start / End Page

118 / 126

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goetz, M. P., Gradishar, W. J., Anderson, B. O., Abraham, J., Aft, R., Allison, K. H., … Kumar, R. (2019). NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw, 17(2), 118–126. https://doi.org/10.6004/jnccn.2019.0009
Goetz, Matthew P., William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Kimberly H. Allison, Sarah L. Blair, et al. “NCCN Guidelines Insights: Breast Cancer, Version 3.2018.J Natl Compr Canc Netw 17, no. 2 (February 2019): 118–26. https://doi.org/10.6004/jnccn.2019.0009.
Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, et al. NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw. 2019 Feb;17(2):118–26.
Goetz, Matthew P., et al. “NCCN Guidelines Insights: Breast Cancer, Version 3.2018.J Natl Compr Canc Netw, vol. 17, no. 2, Feb. 2019, pp. 118–26. Pubmed, doi:10.6004/jnccn.2019.0009.
Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Farrar WB, Giordano SH, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, Moran MS, Mortimer J, O’Regan RM, Patel SA, Pierce LJ, Reed EC, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Telli ML, Ward JH, Young JS, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw. 2019 Feb;17(2):118–126.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2019

Volume

17

Issue

2

Start / End Page

118 / 126

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis